This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Amgen and Onyx Pharmaceuticals Reported to be Near Deal

NEW YORK ( TheStreet) -- Amgen (AMGN - Get Report), the world's largest biotechnology company by sales, is nearing a $10.5 billion deal to buy Onyx Pharamaceuticals (ONXX), according to news reports.

An announcement of a deal could be made as soon as Monday, The New York Times reported Saturday, citing unidentified "people briefed on the matter."

But " the talks could still fall apart before getting to the finish line," The Wall Street Journal reported Saturday, citing an unidentified person familiar with the matter.

If the deal -- said to be worth $125 a share for Onyx shareholders -- is completed, Amgen would gain full rights to Kyprolis, a new drug to treat multiple myeloma, Reuters reported. The drug could reach peak sales of more than $2 billion a year, the news agency said, citing analysts.

A spokesman for Amgen told TheStreet.com that his company had no comment. A similar response was received from a spokeswoman for Onyx.

This article was written by a staff member of TheStreet.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
ONXX $0.00 0.00%
AMGN $163.00 0.38%
AAPL $130.85 -1.40%
FB $81.03 -1.10%
GOOG $554.29 -0.19%

Markets

DOW 18,100.19 +62.22 0.34%
S&P 500 2,113.39 +4.47 0.21%
NASDAQ 5,058.40 -1.8460 -0.04%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs